University of Maryland - Marlene and Stewart Greenebaum Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Maryland - Marlene and Stewart Greenebaum Cancer Center has participated in 5 clinical trials with 2 currently active.
Therapeutic areas: Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Advanced Solid Tumor.
Sponsors: Daiichi Sankyo, Novartis Pharmaceuticals, TransThera Sciences (Nanjing), Inc..
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Maryland - Marlene and Stewart Greenebaum Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Maryland - Marlene and Stewart Greenebaum Cancer Center has 5 clinical trials on record, with 2 currently active. Their work covers Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Advanced Solid Tumor.
Yes — University of Maryland - Marlene and Stewart Greenebaum Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.